Skip to content

Clinical trials

Completed Phase 1/2 Idiopathic Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 1/2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20121
20131
20142
20171
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arrowhead Pharmaceuticals1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Galecto Biotech AB1
Guangdong Raynovent Biotech Co., Ltd1
Institut National de la Santé Et de la Recherche Médicale, France1
Sanofi1
Shanghai East Hospital1
University of Michigan1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis9
Anemia, Aplastic1
Bone Marrow Failure Disorders1
Idiopathic Interstitial Pneumonias1
Lung Diseases, Interstitial1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.